sábado, 20 de enero de 2024

This Frontline Therapy Is Better in Transplant-Ineligible Multiple Myeloma: Study Neil Osterweil

https://www.medscape.com/viewarticle/this-frontline-therapy-better-transplant-ineligible-multiple-2023a1000vj5?ecd=WNL_conf_ash_240119_MSCPEDIT&uac=148436CN&impID=6249196

No hay comentarios:

Publicar un comentario